Persephone Biosciences Inc., a commercial company restoring and reinvigorating the human gut microbiome through clinically validated synergistic synbiotics, today announced that the first subject has ...

From new leadership to product launches, here are five key updates from spine and orthopedic devicemakers since Jan. 15.

J&J’s 2025 results will be the launching point for its guidance of 5%-7% revenue growth for 2025-30, which is still well ...

Johnson & Johnson unveiled financial results that beat Wall Street expectations as the company braces for one of its ...

NBC News surveyed the 15 largest medical device makers and found that just two others — Johnson & Johnson and Medtronic — said they have policies against using unclaimed bodies for research or ...

Barclays lowered the firm’s price target on Johnson & Johnson to $159 from $160 and keeps an Equal Weight rating on the shares. The firm ...

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

Johnson & Johnson refused to add warning labels to its products. The company prioritized sales over consumer safety. By filing a J&J ovarian cancer lawsuit, women across the country may now be able to ...

Ralph Norman and Keith Self, switched their votes for Johnson. (The president-elect called them between ballots, but according to Politico they denied that was the reason for their reversals.

WASHINGTON — House Speaker Mike Johnson is trying to avoid the same fate that his predecessor, Kevin McCarthy, experienced two years ago: an embarrassing, drawn-out floor fight for the speaker ...

One GOP defection in Friday's vote could decide if Johnson gets another term. After spending Thursday trying to sway Republican holdouts to back his bid to retain the speaker's gavel, Mike Johnson ...

Washington — House Speaker Mike Johnson on Thursday met with members of the conservative House Freedom Caucus as his bid for the speakership in the next Congress hangs in the balance.